Govt releases Schedule M guidelines, calls for stricter quality control, recall measure

The Union Health Ministry has notified the Revised Schedule M guidelines under which pharmaceutical companies will have to intimate the licensing authority about recalling a drug and also report product defects, deterioration or faulty production. Till now there was no provision for informing the licensing authority about drug recall.

Schedule M part of Drugs and Cosmetics Act 1940 deals with 'Good Manufacturing Practices' to be followed by pharmaceutical manufacturing units in the country.

For more details, check out the link given below:

Good Manufacturing Practices: Govt Releases Schedule M Guidelines, Calls For Stricter Quality Control, Recall Measures